Reproducibility of DXA Estimations of Body Fat in HIV Lipodystrophy
- 1 September 2005
- journal article
- research article
- Published by Elsevier in Journal of Clinical Densitometry
- Vol. 8 (3) , 293-297
- https://doi.org/10.1385/jcd:8:3:293
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Prospective evaluation of the effects of antiretroviral therapy on body composition in HIV-1-infected men starting therapyAIDS, 2003
- An objective case definition of lipodystrophy in HIV-infected adults: a case-control studyThe Lancet, 2003
- HIV-associated lipodystrophy syndrome: assessment and management.Journal of Infection, 2003
- Agreement Analysis of Variables Involved in Lipodystrophy Syndrome Definition in HIV-Infected PatientsJAIDS Journal of Acquired Immune Deficiency Syndromes, 2003
- Body composition changes in protease inhibitor‐naive HIV‐infected patients treated with two nucleoside reverse transcriptase inhibitorsHIV Medicine, 2002
- HIV-associated lipodystrophy: Description, pathogenesis, and molecular pathwaysCurrent Diabetes Reports, 2002
- Reproducibility of DXA in Obese WomenJournal of Clinical Densitometry, 2002
- Reproducibility of DXA: Potential Impact on Serial Measurements and Misclassification of OsteoporosisOsteoporosis International, 2001
- Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: acohort studyThe Lancet, 1999
- Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistanceThe Lancet, 1998